• Learning Objective 1: Discuss evidence-based strategy for coagulation factor replacement in the management of anticoagulant-associated intracranial hemorrhage
  • Learning Objective 2: Review the process for ordering activated prothrombin complex concentrate(KCentra) and Idarucizumab (Praxbind) at UCM


Session date: 
04/19/2018 - 11:00am to 11:30am CDT
5841 S. Maryland Ave, MC 5068
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Olabisi Falana, PharmD